null
Loading... Please wait...
FREE SHIPPING on All Unbranded Items LEARN MORE
Print This Page

Fentanyl, Inc. (How Rogue Chemists Are Creating the Deadliest Wave of the Opioid Epidemic) - 9780802157379

List Price: $20.00
SKU:
9780802157379
Quantity:
Minimum Purchase
25 unit(s)
  • Availability: Confirm prior to ordering
  • Branding: minimum 50 pieces (add’l costs below)
  • Check Freight Rates (branded products only)

Branding Options (v), Availability & Lead Times

  • 1-Color Imprint: $2.00 ea.
  • Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
  • Belly-Band Wrap: $2.50 ea. (full-color printed)
  • Set-Up Charge: $45 per decoration
FULL DETAILS
  • Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
  • Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
  • Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
  • RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
  • Product Details

    Author:
    Ben Westhoff
    Format:
    Paperback
    Pages:
    352
    Publisher:
    Grove Atlantic (September 22, 2020)
    Language:
    English
    Audience:
    General/trade
    ISBN-13:
    9780802157379
    ISBN-10:
    0802157378
    Dimensions:
    8.25" x 5.5"
    File:
    PGW-LEGATO-Metadata_Only_Publishers_Group_West_Customer_Group_Metadata_20251003164637-20251003.xml
    Folder:
    PGW
    List Price:
    $20.00
    Case Pack:
    44
    As low as:
    $17.20
    Publisher Identifier:
    P-PER
    Discount Code:
    C
    Country of Origin:
    United States
    Pub Discount:
    60
    Weight:
    11.2oz
    Imprint:
    Grove Press
  • Overview

    A remarkable four-year investigation into the dangerous world of synthetic drugs—from black market drug factories in China to users and dealers on the streets of the U.S. to harm reduction activists in Europe—which reveals for the first time the next wave of the opioid epidemic

    A deeply human story, Fentanyl, Inc. is the first deep-dive investigation of a hazardous and illicit industry that has created a worldwide epidemic, ravaging communities and overwhelming and confounding government agencies that are challenged to combat it. “A whole new crop of chemicals is radically changing the recreational drug landscape,” writes Ben Westhoff. “These are known as Novel Psychoactive Substances (NPS) and they include replacements for known drugs like heroin, cocaine, ecstasy, and marijuana. They are synthetic, made in a laboratory, and are much more potent than traditional drugs”—and all-too-often tragically lethal.

    Drugs like fentanyl, K2, and Spice—and those with arcane acronyms like 25i-NBOMe— were all originally conceived in legitimate laboratories for proper scientific and medicinal purposes. Their formulas were then hijacked and manufactured by rogue chemists, largely in China, who change their molecular structures to stay ahead of the law, making the drugs’ effects impossible to predict. Westhoff has infiltrated this shadowy world. He tracks down the little-known scientists who invented these drugs and inadvertently killed thousands, as well as a mysterious drug baron who turned the law upside down in his home country of New Zealand. Westhoff visits the shady factories in China from which these drugs emanate, providing startling and original reporting on how China’s vast chemical industry operates, and how the Chinese government subsidizes it. Poignantly, he chronicles the lives of addicted users and dealers, families of victims, law enforcement officers, and underground drug awareness organizers in the U.S. and Europe. Together they represent the shocking and riveting full anatomy of a calamity we are just beginning to understand. From its depths, as Westhoff relates, are emerging new strategies that may provide essential long-term solutions to the drug crisis that has affected so many.